Rethinking Diabetes: A Weekly Review
Malattie Metaboliche e Diabetologia
Advances in Diabetes Management and Related Endocrinology
This week we explore advances in diabetes management including GLP-1 receptor agonists and SGLT2 inhibitors, examine related endocrine conditions like Hashimoto's thyroiditis, and discuss innovative diagnostic approaches and treatments across the field of endocrinology.
Bibliography
1. Long-term GLP-1 receptor agonist therapy in obesity: expert panel recommendations for good clinical practice.
Authors: Brancato D, Borretta G, Chianelli M, et al.
Journal: Frontiers in endocrinology, 2026
PMID: 42865447
DOI: 10.3389/fendo.2026.1907270
2. A narrative review of what cohorts have taught us and how they have laid the foundation for much of our understanding of type 2 diabetes.
Authors: Kim SH, Arora I, Agyemang C, et al.
Journal: Diabetologia, 2026 Oct
PMID: 42644887
DOI: 10.1007/s00125-026-06812-4
3. Glycemic and Renal Effects of SGLT2 Inhibitors in Monogenic Diabetes: A Real-World National Study.
Authors: Audrain E, Bel Lassen P, Bellanné-Chantelot C, et al.
Journal: Diabetes, obesity & metabolism, 2026 Oct
PMID: 42559753
DOI: 10.1111/dom.71169
4. Effect of Medications for Type 2 Diabetes on Cardiovascular Events and Mortality: A Comprehensive Pairwise and Network Meta-Analysis.
Authors: Silverii GA, Velardi V, Marinelli C, et al.
Journal: Diabetes, obesity & metabolism, 2026 Oct
PMID: 42530338
DOI: 10.1111/dom.71128
5. The Role of Immunological Challenges, Oxidative Stress, and Dietary Interventions in Managing Hashimoto's Thyroiditis: A Narrative Review.
Authors: Morasiewicz-Jeziorek J, Buczyńska A, Krętowski AJ, et al.
Journal: Nutrition reviews, 2026 Oct 1
PMID: 41498438
DOI: 10.1093/nutrit/nuaf195
6. Type 2 diabetes subtypes for precision medicine: methodological challenges and alternative prediction-based approaches.
Authors: Mori T, Herder C, Cardoso P, et al.
Journal: Diabetologia, 2026 Oct
PMID: 42502138
DOI: 10.1007/s00125-026-06802-6
7. 68Ga-DOTA-exendin-4 PET/CT for insulinoma localization in patients with negative or inconclusive conventional imaging.
Authors: Fricke JG, Laubner K, Schildmeijer M, et al.
Journal: The Journal of clinical endocrinology and metabolism, 2026 Oct 16
PMID: 42168767
DOI: 10.1210/clinem/dgag214
8. Osteoporosis in Pediatric Orthopaedics: Congenital Diseases, Medical Management, and Perioperative Considerations.
Authors: Puryear AS, Bess LE, DiMeglio LA
Journal: Current osteoporosis reports, 2026 Oct 6
PMID: 42837075
DOI: 10.1007/s11914-026-00985-y
9. Prognostic factors for mortality in ST-elevation myocardial infarction in individuals with diabetes: A systematic review with implications for risk stratification and therapeutic considerations.
Authors: Ipek R, Schaefer E, Neuenschwander M, et al.
Journal: Pharmacology & therapeutics, 2026 Oct
PMID: 42471062
DOI: 10.1016/j.pharmthera.2026.109083
10. Aldosterone synthase inhibitors: biological rationale, mechanism of action, and results of clinical trials.
Authors: Surma S, Narkiewicz K
Journal: American journal of hypertension, 2026 Oct 1
PMID: 42847230
DOI: 10.1093/ajh/hpag087
Authors: Brancato D, Borretta G, Chianelli M, et al.
Journal: Frontiers in endocrinology, 2026
PMID: 42865447
DOI: 10.3389/fendo.2026.1907270
2. A narrative review of what cohorts have taught us and how they have laid the foundation for much of our understanding of type 2 diabetes.
Authors: Kim SH, Arora I, Agyemang C, et al.
Journal: Diabetologia, 2026 Oct
PMID: 42644887
DOI: 10.1007/s00125-026-06812-4
3. Glycemic and Renal Effects of SGLT2 Inhibitors in Monogenic Diabetes: A Real-World National Study.
Authors: Audrain E, Bel Lassen P, Bellanné-Chantelot C, et al.
Journal: Diabetes, obesity & metabolism, 2026 Oct
PMID: 42559753
DOI: 10.1111/dom.71169
4. Effect of Medications for Type 2 Diabetes on Cardiovascular Events and Mortality: A Comprehensive Pairwise and Network Meta-Analysis.
Authors: Silverii GA, Velardi V, Marinelli C, et al.
Journal: Diabetes, obesity & metabolism, 2026 Oct
PMID: 42530338
DOI: 10.1111/dom.71128
5. The Role of Immunological Challenges, Oxidative Stress, and Dietary Interventions in Managing Hashimoto's Thyroiditis: A Narrative Review.
Authors: Morasiewicz-Jeziorek J, Buczyńska A, Krętowski AJ, et al.
Journal: Nutrition reviews, 2026 Oct 1
PMID: 41498438
DOI: 10.1093/nutrit/nuaf195
6. Type 2 diabetes subtypes for precision medicine: methodological challenges and alternative prediction-based approaches.
Authors: Mori T, Herder C, Cardoso P, et al.
Journal: Diabetologia, 2026 Oct
PMID: 42502138
DOI: 10.1007/s00125-026-06802-6
7. 68Ga-DOTA-exendin-4 PET/CT for insulinoma localization in patients with negative or inconclusive conventional imaging.
Authors: Fricke JG, Laubner K, Schildmeijer M, et al.
Journal: The Journal of clinical endocrinology and metabolism, 2026 Oct 16
PMID: 42168767
DOI: 10.1210/clinem/dgag214
8. Osteoporosis in Pediatric Orthopaedics: Congenital Diseases, Medical Management, and Perioperative Considerations.
Authors: Puryear AS, Bess LE, DiMeglio LA
Journal: Current osteoporosis reports, 2026 Oct 6
PMID: 42837075
DOI: 10.1007/s11914-026-00985-y
9. Prognostic factors for mortality in ST-elevation myocardial infarction in individuals with diabetes: A systematic review with implications for risk stratification and therapeutic considerations.
Authors: Ipek R, Schaefer E, Neuenschwander M, et al.
Journal: Pharmacology & therapeutics, 2026 Oct
PMID: 42471062
DOI: 10.1016/j.pharmthera.2026.109083
10. Aldosterone synthase inhibitors: biological rationale, mechanism of action, and results of clinical trials.
Authors: Surma S, Narkiewicz K
Journal: American journal of hypertension, 2026 Oct 1
PMID: 42847230
DOI: 10.1093/ajh/hpag087
